Is the performance on pretreatment exposure, assessed by the BAT-procedure, related to symptom change after 12 weeks of specialized clinical CBT, in patients with Obsessive-Compulsive Disorder?
Completed
- Conditions
- obsessive compulsive disorder10002861
- Registration Number
- NL-OMON43347
- Lead Sponsor
- GGZ Centraal (Amersfoort)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Referred patients (aged >18years), who meet a primary DSM-IV diagnosis of OCD, follow a specialized residential treatment with CBT as main component and give informed consent.
Exclusion Criteria
Referred patients suffering from a psychotic disorder, an organic mental disorder, substance dependence, or mental retardation.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Dependent variables:<br /><br>1/ Difference in score on YBOCS assessed at start of treatment and after 12<br /><br>weeks (continuous data);<br /><br>2/ Response to treatment (>=35% OCD symptom reduction) yes/no;<br /><br>3/ Remission (post-treatment YBOCS score <=8) yes/no.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome measures will be<br /><br>- Difference in score on quality of life, assessed by the Euroquol at start of<br /><br>treatment and after 12 weeks.<br /><br>- Proportion of dropouts.<br /><br>- Outcome at 16 and 40 weeks. </p><br>